Perrigo Company plc (PIG) - Net Assets

Latest as of December 2025: €2.94 Billion EUR ≈ $3.43 Billion USD

Based on the latest financial reports, Perrigo Company plc (PIG) has net assets worth €2.94 Billion EUR (≈ $3.43 Billion USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€8.54 Billion ≈ $9.98 Billion USD) and total liabilities (€5.60 Billion ≈ $6.55 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Perrigo Company plc tangible equity quality to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric Value
Current Net Assets €2.94 Billion
% of Total Assets 34.39%
Annual Growth Rate -7.56%
5-Year Change -43.02%
10-Year Change N/A
Growth Volatility 9.94

Perrigo Company plc - Net Assets Trend (2016–2025)

This chart illustrates how Perrigo Company plc's net assets have evolved over time, based on quarterly financial data. See Perrigo Company plc (PIG) defensive interval to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Perrigo Company plc (2016–2025)

The table below shows the annual net assets of Perrigo Company plc from 2016 to 2025. For live valuation and market cap data, see Perrigo Company plc stock valuation.

Year Net Assets Change
2025-12-31 €2.94 Billion
≈ $3.43 Billion		 -32.04%
2024-12-31 €4.32 Billion
≈ $5.05 Billion		 -9.41%
2023-12-31 €4.77 Billion
≈ $5.57 Billion		 -1.53%
2022-12-31 €4.84 Billion
≈ $5.66 Billion		 -6.01%
2021-12-31 €5.15 Billion
≈ $6.02 Billion		 -8.90%
2020-12-31 €5.66 Billion
≈ $6.61 Billion		 -2.57%
2019-12-31 €5.80 Billion
≈ $6.79 Billion		 +2.40%
2018-12-31 €5.67 Billion
≈ $6.63 Billion		 -8.14%
2017-12-31 €6.17 Billion
≈ $7.21 Billion		 +3.58%
2016-12-31 €5.96 Billion
≈ $6.97 Billion		 --

Equity Component Analysis

This analysis shows how different components contribute to Perrigo Company plc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 158240000000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Other Components €6.61 Billion 225.28%
Total Equity €2.94 Billion 100.00%

Perrigo Company plc Competitors by Market Cap

The table below lists competitors of Perrigo Company plc ranked by their market capitalization.

Company Market Cap
Aotecar New Energy Technology Co Ltd
SHE:002239
 $1.28 Billion
Lihuayi Weiyuan Chemical Co Ltd
SHG:600955
 $1.28 Billion
Wangneng Environment Co Ltd
SHE:002034
 $1.28 Billion
Zhejiang Hisoar Pharmaceutical Co Ltd
SHE:002099
 $1.28 Billion
Cpi Fim SA
WAR:OPG
 $1.28 Billion
Rusta AB (publ)
ST:RUSTA
 $1.28 Billion
JM Financial Limited
NSE:JMFINANCIL
 $1.28 Billion
COSMO Pharmaceuticals SA
SW:COPN
 $1.28 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Perrigo Company plc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 4,319,400,000 to 2,935,500,000, a change of -1,383,900,000 (-32.0%).
  • Net loss of 1,425,400,000 reduced equity.
  • Dividend payments of 159,300,000 reduced retained earnings.
  • Other factors increased equity by 200,800,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income €-1.43 Billion -48.56%
Dividends Paid €159.30 Million -5.43%
Other Changes €200.80 Million +6.84%
Total Change €- -32.04%

Book Value vs Market Value Analysis

This analysis compares Perrigo Company plc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.44x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has increased from 0.21x to 0.44x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2017-12-31 €43.82 €9.41 x
2018-12-31 €41.71 €9.41 x
2019-12-31 €42.64 €9.41 x
2020-12-31 €42.49 €9.41 x
2021-12-31 €38.50 €9.41 x
2022-12-31 €35.95 €9.41 x
2023-12-31 €35.19 €9.41 x
2024-12-31 €31.66 €9.41 x
2025-12-31 €21.33 €9.41 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Perrigo Company plc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -48.56%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -33.51%
  • • Asset Turnover: 0.50x
  • • Equity Multiplier: 2.91x
  • Recent ROE (-48.56%) is below the historical average (-12.05%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2016 -67.35% -75.99% 0.38x 2.33x €-4.61 Billion
2017 1.94% 2.42% 0.43x 1.88x €-497.45 Million
2018 2.31% 2.77% 0.43x 1.94x €-435.80 Million
2019 2.52% 3.02% 0.43x 1.95x €-434.28 Million
2020 -2.88% -3.21% 0.44x 2.03x €-728.11 Million
2021 -1.34% -1.66% 0.40x 2.02x €-584.07 Million
2022 -2.90% -3.16% 0.40x 2.28x €-624.81 Million
2023 -0.27% -0.27% 0.43x 2.27x €-489.49 Million
2024 -3.98% -3.93% 0.45x 2.23x €-603.74 Million
2025 -48.56% -33.51% 0.50x 2.91x €-1.72 Billion

Industry Comparison

This section compares Perrigo Company plc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $6,711,906,287
  • Average return on equity (ROE) among peers: -52.40%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Perrigo Company plc (PIG) €2.94 Billion -67.35% 1.91x $1.28 Billion
SHANG.FOS.PHARM.GR.H YC 1 (08HH) $59.93 Billion 4.62% 0.96x $1.14 Billion
PEPTONIC MEDICAL (28L) $53.12 Million -138.73% 0.59x $4.14 Million
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) $6.65 Billion 14.85% 0.54x $692.11 Million
WEST ISLAND BRANDS INC. (39N0) $3.27 Million -157.21% 0.88x $1.34 Million
AYURCANN HOLDINGS CORP. (3ZQ0) $2.69 Million -197.11% 3.73x $97.35K
CERENO SCIENTIFIC AB B (4A1) $252.47 Million -46.64% 0.59x $157.72 Million
MAPLE LEAF GREEN WORLD (4HV0) $-8.83 Million 0.00% 0.00x $504.30K
LORDS CO. WORLDW. HOLD. (4XM) $-1.01 Million 0.00% 0.00x $134.78K
RED LIGHT HOLLAND CORP. (4YX) $17.35 Million -23.30% 0.22x $13.93 Million
EQL PHARMA AB (7JK) $221.03 Million 19.51% 2.66x $78.02 Million

About Perrigo Company plc

F:PIG Germany Drug Manufacturers - Specialty & Generic
Market Cap
$1.52 Billion
€1.30 Billion EUR
Market Cap Rank
#8029 Global
#1061 in Germany
Share Price
€9.41
Change (1 day)
+1.42%
52-Week Range
€7.82 - €24.22
All Time High
€125.23
Categories
Companies in Germany Drug Manufacturers - Specialty & Generic
About

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and ora… Read more